Winning Health Technology Group Co., Ltd.
Shenzhen Stock ExchangeTotal Valuation
Winning Health Technology Group Co., Ltd. carries a market capitalization of 15.01B, placing it among publicly traded companies globally. Its enterprise value stands at 23.15B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 15.01B |
| Enterprise Value | 23.15B |
Share Statistics
Winning Health Technology Group Co., Ltd. currently has 2.21B shares outstanding.
| Shares Outstanding | 2.21B |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Winning Health Technology Group Co., Ltd. trades at a trailing price-to-earnings ratio of 132.75. The price-to-sales ratio is 9.74, and the price-to-book ratio stands at 5.15.
| PE Ratio | 132.75 |
| PS Ratio | 9.74 |
| PB Ratio | 5.15 |
| P/TBV Ratio | 6.17 |
| P/FCF Ratio | 87.04 |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Winning Health Technology Group Co., Ltd. trades at an EV/EBITDA multiple of 64.17 and an EV/FCF ratio of 68.95. The EV/Sales ratio of 9.66 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 64.17 provides insight into valuation relative to core operating earnings.
| EV / Sales | 9.66 |
| EV / EBITDA | 64.17 |
| EV / EBIT | 64.17 |
| EV / FCF | 68.95 |
Financial Position
Winning Health Technology Group Co., Ltd. maintains a current ratio of 3.22, meaning it holds 3.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 19.49, indicating elevated leverage, while an interest coverage ratio of 5.43 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 3.22 |
| Quick Ratio | 0.89 |
| Debt / Equity | 19.49 |
| Debt / EBITDA | 3.16 |
| Interest Coverage | 5.43 |
Financial Efficiency
| Return on Equity (ROE) | -1.32 |
| Return on Assets (ROA) | -0.71 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 11.14 |
Taxes
| Income Tax | 1.27M |
| Effective Tax Rate | N/A |
Stock Price Statistics
Winning Health Technology Group Co., Ltd.'s stock has declined approximately -30.97166% over the past 52 weeks. The 50-day moving average sits at 8.00, while the 200-day moving average is 9.05.
| Beta (5Y) | N/A |
| 52-Week Price Change | -30.97166% |
| 50-Day Moving Average | 8.00 |
| 200-Day Moving Average | 9.05 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Winning Health Technology Group Co., Ltd. generated 2.40B in revenue and converted that into -60.24M in net income, yielding earnings per share of -0.04. EBITDA reached 360.82M, while operating income came in at 360.82M.
| Revenue | 2.40B |
| Gross Profit | 959.15M |
| Operating Income | 360.82M |
| Pretax Income | -93.70M |
| Net Income | -60.24M |
| EBITDA | 360.82M |
| EBIT | 360.82M |
| Earnings Per Share (EPS) | -0.04 |
Balance Sheet
Winning Health Technology Group Co., Ltd. holds 1.33B in cash and equivalents against 1.14B in total debt, resulting in a net debt position of -238.77M. Total book value stands at 4.53B, with working capital of 3.34B providing operational flexibility.
| Cash & Cash Equivalents | 1.33B |
| Total Debt | 1.14B |
| Net Debt | -238.77M |
| Equity (Book Value) | 4.53B |
| Book Value Per Share | 2.06 |
| Working Capital | 3.34B |
Cash Flow
After subtracting -268.40M in capital expenditures, free cash flow totaled -268.40M - equivalent to -0.12 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -268.40M |
| Free Cash Flow | -268.40M |
| FCF Per Share | -0.12 |
Margins
Winning Health Technology Group Co., Ltd. operates with a gross margin of 40.00, reflecting its pricing power and cost economics. The operating margin of 15.05 and net profit margin of -2.51 provide insight into operational efficiency.
| Gross Margin | 40.00 |
| Operating Margin | 15.05 |
| Pretax Margin | -3.91 |
| Profit Margin | -2.51 |
| EBITDA Margin | 15.05 |
Dividends & Yields
The company's payout ratio of -38.61 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.02 |
| Dividend Yield | N/A |
| Payout Ratio | -38.61 |
| Shareholder Yield | -0.79 |
| FCF Yield | 1.15 |
Stock Splits
Winning Health Technology Group Co., Ltd.'s most recent stock split took place on June 22, 2020 with a 10:13 split ratio.
| Last Split Date | 6/22/2020 |
| Split Ratio | 10:13 |
Scores
Winning Health Technology Group Co., Ltd. posts an Altman Z-Score of 6.87, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 6.87 |